Search - tctmd.com

Displaying 981 - 1000 of 1094

Sort: Relevancy | Date

News Industry News

Case Report: Use of OrbusNeich’s Genous™ Stent with Bivalirudin for Acute Coronary Syndrome Patients at Risk for Bleeding Due to Hematological Cancer

December 16, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News TCT 2012

Stroke Prevention Strategies Discussed

October 26, 2012

News Industry News

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

October 23, 2012

News Daily News

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

October 19, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

Yael L. Maxwell

October 12, 2012

News Daily News

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

October 12, 2012

News Daily News

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

L.A. McKeown

October 10, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

News Daily News

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

Caitlin E. Cox

October 04, 2012

News Daily News

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Caitlin E. Cox

October 04, 2012

News Daily News

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

October 02, 2012

News Daily News

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

October 02, 2012

News Daily News

La Escala de Riesgo Predice los ACV o Muerte en Candidatos a recibir un Stent de Carótida

Jason Kahn

September 28, 2012

News Daily News

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

September 27, 2012

News Daily News

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

September 27, 2012

News Daily News

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

September 12, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

Advertisement

Case Report: Use of OrbusNeich’s Genous™ Stent with Bivalirudin for Acute Coronary Syndrome Patients at Risk for Bleeding Due to Hematological Cancer

Evidence Continues to Support Dabigatran Treatment in A-fib

Stroke Prevention Strategies Discussed

Boston Scientific Demonstrates Ongoing Structural Heart Advances at Transcatheter Cardiovascular Therapeutics 2012 in Miami

Una Nueva Clase de Anticoagulantes Orales resulta Segura comparada con la Warfarina para Pacientes con FA

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Un Nuevo Dispositivo Resulta Prometedor para el Cierre Seguro y Eficaz del AAI

En la PCI Transradial, comparada con la Heparina, la Bivalirudina No Altera los Índices de Episodios

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

Apixaban Surpasses Warfarin At All Risk Levels in A-Fib Patients

El Apixaban Supera a la Warfarina a Todos los Niveles de Riesgo en Pacientes con FA

Un Meta análisis estudia Nuevos Anticoagulantes + Terapia Doble en Pacientes que han sufrido un SCA

Meta-analysis Looks at Novel Anticoagulants Plus Dual Therapy in ACS Patients

La Escala de Riesgo Predice los ACV o Muerte en Candidatos a recibir un Stent de Carótida

Watchman Device for LAA Closure Provides Net Clinical Benefit vs. Warfarin in A-fib Patients

El Dispositivo Watchman para el Cierre del AAI Ofrece Beneficios Clínicos Netos comparado con la Warfarina en Pacientes con FA

El Uso del Dabigatran va a Más tanto contra la FA como Fuera de Indicación

Dabigatran Usage up, Both for A-fib and Off-Label Indications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content